|
|
? |
SOUTH AFRICA: Aspen eyes African AIDS drug market
[This report does not necessarily reflect the views of the United Nations]
JOHANNESBURG, 24 August (PLUSNEWS) - South African generic drug maker Aspen Pharmacare says it is eyeing Africa's anti-AIDS drugs market, which has huge potential demand.
Aspen CEO Stephen Saad said only 8 percent of the approximately 4 million people in sub-Saharan Africa who needed treatment for HIV/AIDS were receiving it.
The local Business Day newspaper quoted him as saying, "Antiretroviral medicines are becoming a bigger and bigger part of our production - we could never have foreseen this growth."
Aspen has approval from the US Federal Drug Administration for some of its anti-AIDS drugs, and was recently also awarded the lion's share of the South African government's antiretroviral drug tenders.
[ENDS]
MORE NEWS BRIEFS
|
|
? |
|
|
|
|
|
| Links |
Le portail d'informations générales de la Côte d’Ivoire
|
Sida Info Services
|
Le Fonds mondial de lutte contre le SIDA, la tuberculose et le paludisme
|
Le Réseau Afrique 2000
|
The Global Fund to fight AIDS, Tuberculosis & Malaria
|
PlusNews does not take responsibility for info in links supplied. |
|
|
|
|
|
[Back] [Home Page]
Click here to send any feedback,
comments or questions you have about PlusNews Website or if you prefer you can
send an Email to Webmaster
Copyright ? IRIN 2005
The material contained on www.PlusNews.org comes to you via IRIN, a UN humanitarian news and information service, but may not necessarily reflect
the views of the United Nations or its agencies.
All PlusNews material may be reposted or reprinted free-of-charge; refer to the IRIN copyright page for conditions of use. IRIN is a project of the UN
Office for the Coordination of Humanitarian Affairs.
|